138 related articles for article (PubMed ID: 2163354)
1. The diagnostic significance of the CD30 (Ki-1) antigen.
Pallesen G
Histopathology; 1990 Apr; 16(4):409-13. PubMed ID: 2163354
[No Abstract] [Full Text] [Related]
2. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
Carbone A; Gloghini A; Volpe R
Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
[TBL] [Abstract][Full Text] [Related]
3. [Ki-1 lymphoma histologically mimicking Hodgkin's disease].
Watanaba K; Naito M; Tanahashi N; Nara M; Kobayashi H; Shimbo T; Kojima M
Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):964-5. PubMed ID: 2551983
[No Abstract] [Full Text] [Related]
4. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
5. Ki-1 positive meningeal lymphoma in a patient with a history of Hodgkin lymphoma.
Serena M; Tonetto G; Belli P
Ital J Neurol Sci; 1991 Feb; 12(1):93-7. PubMed ID: 1849505
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD30 as a biomarker to predict response to brentuximab vedotin.
Xu ML; Acevedo-Gadea C; Seropian S; Katz SG
Histopathology; 2016 Jul; 69(1):155-8. PubMed ID: 26648051
[No Abstract] [Full Text] [Related]
7. Ultrastructure of 26 cases of Ki-1 lymphomas: morphoimmunologic correlation.
Rivas C; Piris MA; Gamallo C; Barat A; Echezarreta G; Oliva H; Sarasa JL; Rivas F; Renedo G; Martin C
Ultrastruct Pathol; 1990; 14(5):381-97. PubMed ID: 2174195
[TBL] [Abstract][Full Text] [Related]
8. CD30 expression in follicular lymphoma.
Piris M; Gatter KC; Mason DY
Histopathology; 1991 Jan; 18(1):25-9. PubMed ID: 1849500
[TBL] [Abstract][Full Text] [Related]
9. CD30 expression in non-Hodgkin's lymphoma.
Piris M; Brown DC; Gatter KC; Mason DY
Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674
[TBL] [Abstract][Full Text] [Related]
10. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
11. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.
Falini B; Pileri S; Pizzolo G; Dürkop H; Flenghi L; Stirpe F; Martelli MF; Stein H
Blood; 1995 Jan; 85(1):1-14. PubMed ID: 7803786
[No Abstract] [Full Text] [Related]
12. Primary anaplastic large cell lymphoma of the skin.
Berti E; Gianotti R; Alessi E
Dermatologica; 1989; 178(4):225-7. PubMed ID: 2548900
[TBL] [Abstract][Full Text] [Related]
13. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic large cell Ki-l lymphoma.
Chong SM; Wong SY
Histopathology; 1990 Mar; 16(3):315-6. PubMed ID: 2369457
[No Abstract] [Full Text] [Related]
15. Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations.
Abbondanzo SL; Sato N; Straus SE; Jaffe ES
Am J Clin Pathol; 1990 May; 93(5):698-702. PubMed ID: 2158227
[TBL] [Abstract][Full Text] [Related]
16. Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen.
Schnell R; Linnartz C; Katouzi AA; Schön G; Bohlen H; Horn-Lohrens O; Parwaresch RM; Lange H; Diehl V; Lemke H
Int J Cancer; 1995 Oct; 63(2):238-44. PubMed ID: 7591211
[TBL] [Abstract][Full Text] [Related]
17. Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).
Andreesen R; Brugger W; Löhr GW; Bross KJ
Am J Pathol; 1989 Jan; 134(1):187-92. PubMed ID: 2536522
[TBL] [Abstract][Full Text] [Related]
18. Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.
Pohl C; Renner C; Schwonzen M; Sieber M; Lorenz P; Pfreundschuh M; Diehl V
Int J Cancer; 1992 Apr; 50(6):958-67. PubMed ID: 1313400
[TBL] [Abstract][Full Text] [Related]
19. Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas.
Kaudewitz P; Burg G; Stein H
Curr Probl Dermatol; 1990; 19():150-6. PubMed ID: 2153506
[No Abstract] [Full Text] [Related]
20. Ki-1 lymphoma and Hodgkin's disease.
Pileri S; Mazza P; Zinzani PL; Poggi S; Poletti G; Falini B; Tura S
Haematologica; 1989; 74(3):333-4. PubMed ID: 2555287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
